Menu
Recruiting NCT07552571

Goal Commitment and Proactive Health Behavior in Chronic Disease Patients

No phase Interventional Hypertension Diabetes Mellitus Dyslipidemia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Goal Commitment-Based Behavioral Intervention, Usual Care.
Who it may be relevant to
Registry conditions: Hypertension, Diabetes Mellitus, Dyslipidemia. Basic parameters: from 45 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Evolution and Driving Mechanism of Proactive Health Behavior in Chronic Disease Patients Based on Goal Commitment

Overview

Chronic diseases such as hypertension, diabetes, and dyslipidemia are major contributors to mortality and healthcare burden worldwide. Despite high awareness of health risks, many patients fail to adopt proactive health behaviors due to behavioral inertia and a gap between knowledge and action. This study aims to investigate the evolution and driving mechanisms of proactive health behavior in patients with chronic diseases based on goal commitment theory. By integrating prospect theory and evolutionary game theory, this study will explore how behavioral strategies evolve under different levels of goal commitment. In addition, a behavioral intervention based on the Stimulus-Organism-Response (SOR) model will be developed to enhance patient activation and promote adherence to proactive health behaviors. A parallel controlled intervention study will be conducted to evaluate the effectiveness of the goal commitment-based intervention. The findings of this study are expected to provide theoretical and practical evidence to improve chronic disease management and promote proactive health behaviors.

Detailed description

Chronic diseases, including hypertension, diabetes, and dyslipidemia, account for a substantial proportion of morbidity, mortality, and healthcare expenditure. Although a large proportion of patients are aware of their health risks, more than half fail to adopt proactive health behaviors. This gap between awareness and action is often attributed to behavioral inertia and insufficient motivation.

This study aims to explore the evolution and driving mechanisms of proactive health behavior among patients with chronic diseases based on goal commitment theory. The theoretical framework integrates prospect theory and evolutionary game theory to model behavioral decision-making under uncertainty and dynamic interactions.

First, a theoretical model will be constructed to simulate the evolution of proactive health behaviors under different levels of goal commitment, using evolutionary game analysis. Second, a conceptual framework based on the Stimulus-Organism-Response (SOR) model will be developed to examine how goal commitment influences patient activation and social norms, thereby affecting proactive health behavior.

Empirical data will be collected through multi-site surveys among patients with chronic diseases. Subsequently, a parallel controlled intervention study will be conducted to evaluate the effectiveness of a goal commitment-based intervention in improving proactive health behaviors.

Inclusion criteria include adult residents diagnosed with at least one chronic condition (hypertension, diabetes, or dyslipidemia), with adequate cognitive ability and willingness to participate. Exclusion criteria include inability to participate in group activities, current hospitalization, or severe psychiatric or cognitive disorders.

The study is expected to provide insights into the mechanisms underlying proactive health behavior and offer evidence-based strategies for improving chronic disease management.

Interventions

  • Behavioral Goal Commitment-Based Behavioral Intervention
    This intervention is a structured behavioral program based on goal commitment theory, designed to promote proactive health behaviors in patients with chronic diseases. The intervention includes goal setting, personalized action planning, behavioral activation, and continuous follow-up support. Participants will receive guidance to enhance motivation, strengthen commitment to health goals, and improve adherence to chronic disease management through regular monitoring and feedback.
  • Other Usual Care
    Participants in the control group will receive routine chronic disease management or standard health education without additional structured behavioral intervention.

Primary outcome measures

  • Change in Proactive Health Behavior Score [Time frame: Baseline to 6 months after intervention]
Secondary outcome measures (12)
  • Change in Metabolic Syndrome (MetS) Score [Time frame: Baseline to 6 months after intervention]
  • Change in Proactive Health Behavior Score at 3 Months [Time frame: Baseline to 3 months after intervention]
  • Change in Fasting Blood Glucose (FBG) at 3 Months [Time frame: Baseline to 3 months after intervention]
  • Change in Fasting Blood Glucose (FBG) [Time frame: Baseline, 3 months, and 6 months after intervention]
  • Change in Triglycerides (TG) [Time frame: Baseline, 3 months after intervention, and 6 months after intervention]
  • Change in High-Density Lipoprotein Cholesterol (HDL-C) [Time frame: Baseline, 3 months after intervention, and 6 months after intervention]
  • Change in Blood Pressure [Time frame: Baseline, 3 months after intervention, and 6 months after intervention]
  • Change in Body Mass Index (BMI) at 3 Months [Time frame: Baseline to 3 months after intervention]
  • Change in Triglycerides (TG) at 3 Months [Time frame: Baseline to 3 months after intervention]
  • Change in High-Density Lipoprotein Cholesterol (HDL-C) at 3 Months [Time frame: Baseline to 3 months after intervention]
  • Change in Systolic Blood Pressure (SBP) at 3 Months [Time frame: Baseline to 3 months after intervention]
  • Change in Diastolic Blood Pressure (DBP) at 3 Months [Time frame: Baseline to 3 months after intervention]

Eligibility criteria

Inclusion criteria

  • Residents living in the study area for at least 1.5 years
  • Diagnosed with at least one chronic disease, including hypertension, diabetes mellitus, or dyslipidemia
  • Conscious and able to communicate effectively
  • Educational level of primary school or above
  • Able to use a smartphone and common mobile applications (e.g., WeChat)
  • Willing to participate and provide written informed consent

Exclusion criteria

  • Non-residents of the study area
  • Unable to participate in group-based intervention activities
  • Currently hospitalized
  • Diagnosed with severe cognitive impairment, dementia, or psychiatric disorders
  • Participants with severe comorbidities that may interfere with study participation

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Health services research

Study locations

China · 1 center
  • School of Medicine and Health Management Tongji Medical College,Huazhong University of Sci — Wuhan

Identifiers

NCT: NCT07552571 · SMHM-2026-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗